|
Metronidazole Clinical Trials
6 actively recruiting trials across 4 locations
Also known as: Antibiotic, Flagyl
Pipeline
Phase 2: 5Phase 4: 1
Top Sponsors
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
- M.D. Anderson Cancer Center1
- Leiden University Medical Center1
- Icahn School of Medicine at Mount Sinai1
- Case Comprehensive Cancer Center1
Indications
- Cancer6
- Pancreatic Cancer2
- Rectal Cancer, Adenocarcinoma1
- Rectal Adenocarcinoma1
- Oral Squamous Cell Carcinoma1
Other2 trials
Baltimore, Maryland1 trial
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2
New York, New York1 trial
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2
Cleveland, Ohio1 trial
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Case Comprehensive Cancer Center, Cleveland Clinic Foundation
Phase 2
Houston, Texas1 trial
Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
MD Anderson Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.